StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Earnings

Regenerative Medical Technology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q1 FY2025
$1.35M
EPS, Q1 FY2025
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Regenerative Medical Technology's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2025ended Mar 31, 2025May 21, 2025before the open$1.35M––Release
Q3 FY2024ended Sep 30, 2024Nov 19, 2024before the open$986.31K––Release
Q1 FY2024ended Mar 31, 2024May 23, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Regenerative Medical Technology has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Regenerative Medical Technology puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Regenerative Medical Technology filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?